Acorn Capital Advisors, LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0002054410

Type: FundHoldings: 22Value: $149.9MLatest: 2025Q1

ACORN CAPITAL ADVISORS, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 22 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TRVI",
  "BCAX",
  "TERN",
  "ACRV",
  "BCAB",
  "OKUR",
  "PBYI",
  "QTTB",
  "WHWK",
  "CYBN",
  "TARA",
  "AURA",
  "URGN",
  "VSTM",
  "VYNE",
  "XFOR",
  "YMAB",
  "OPTN",
  "MURA",
  "CADL",
  "CRDF",
  "CGON"
]

Filing Details

13F-HR/A • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-19
Total Holdings: 22
Total Value: 149945296
Accession Number: 0001636587-25-000021
Form Type: 13F-HR/A
CIK: acorn-capital-advisors
Manager Name: Acorn-Capital-Advisors

Data Enrichment

100% identified

22 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

22 positions • $149.9M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

CG Oncology, Inc.

CGON|156944100

Shares:1.1M

Value:$27.7M

% of Portfolio:18.5% ($27.7M/$149.9M)

UroGen Pharma Ltd.

URGN|M96088105

Shares:1.5M

Value:$16.8M

% of Portfolio:11.2% ($16.8M/$149.9M)

Y-mAbs Therapeutics, Inc.

YMAB|984241109

Shares:3.2M

Value:$14.3M

% of Portfolio:9.6% ($14.3M/$149.9M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:2.1M

Value:$13.5M

% of Portfolio:9.0% ($13.5M/$149.9M)

Candel Therapeutics, Inc.

CADL|137404109

Shares:2.2M

Value:$12.2M

% of Portfolio:8.1% ($12.2M/$149.9M)

PUMA BIOTECHNOLOGY, INC.

PBYI|74587V107

Shares:3.9M

Value:$11.7M

% of Portfolio:7.8% ($11.7M/$149.9M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:643.4K

Value:$8.4M

% of Portfolio:5.6% ($8.4M/$149.9M)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:1.3M

Value:$5.5M

% of Portfolio:3.6% ($5.5M/$149.9M)

Terns Pharmaceuticals, Inc.

TERN|880881107

Shares:2.0M

Value:$5.4M

% of Portfolio:3.6% ($5.4M/$149.9M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:1.4M

Value:$5.1M

% of Portfolio:3.4% ($5.1M/$149.9M)

Verastem, Inc.

VSTM|92337C203

Shares:779.5K

Value:$4.7M

% of Portfolio:3.1% ($4.7M/$149.9M)

CYBIN INC.

CYBN|23256X407

Shares:734.4K

Value:$4.7M

% of Portfolio:3.1% ($4.7M/$149.9M)

Cardiff Oncology, Inc.

CRDF|14147L108

Shares:1.4M

Value:$4.5M

% of Portfolio:3.0% ($4.5M/$149.9M)

OptiNose, Inc.

OPTN|68404V209

Shares:422.8K

Value:$3.9M

% of Portfolio:2.6% ($3.9M/$149.9M)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:1.1M

Value:$2.0M

% of Portfolio:1.4% ($2.0M/$149.9M)

X4 Pharmaceuticals, Inc

XFOR|98420X103

Shares:7.3M

Value:$1.8M

% of Portfolio:1.2% ($1.8M/$149.9M)

Mural Oncology plc

MURA|G63365103

Shares:1.3M

Value:$1.6M

% of Portfolio:1.1% ($1.6M/$149.9M)

Aura Biosciences, Inc.

AURA|05153U107

Shares:590.5K

Value:$1.5M

% of Portfolio:1.0% ($1.5M/$149.9M)

BioAtla, Inc.

BCAB|09077B104

Shares:4.0M

Value:$1.4M

% of Portfolio:0.9% ($1.4M/$149.9M)

Q32 Bio Inc.

QTTB|746964105

Shares:803.4K

Value:$1.3M

% of Portfolio:0.9% ($1.3M/$149.9M)

Instrument	Shares		Other Manager	Value	% of Portfolio
CG Oncology, Inc.(CGONcusip156944100)	1.1M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$27.7M	18.5% ($27.7M/$149.9M)	QoQ -14.57% (-$4.7M) YoY-
UroGen Pharma Ltd.(URGNcusipM96088105)	1.5M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$16.8M	11.2% ($16.8M/$149.9M)	QoQ +3.84% (+$621.7K) YoY-
Y-mAbs Therapeutics, Inc.(YMABcusip984241109)	3.2M	QoQ +13.05% (-373.6K) YoY-	All Managers (Combined)	$14.3M	9.6% ($14.3M/$149.9M)	QoQ -36.03% (-$8.1M) YoY-
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	2.1M	QoQ +7.18% (+143.8K) YoY-	All Managers (Combined)	$13.5M	9.0% ($13.5M/$149.9M)	QoQ +63.64% (+$5.2M) YoY-
Candel Therapeutics, Inc.(CADLcusip137404109)	2.2M	QoQ +10.96% (-212.6K) YoY-	All Managers (Combined)	$12.2M	8.1% ($12.2M/$149.9M)	QoQ -27.77% (-$4.7M) YoY-
PUMA BIOTECHNOLOGY, INC.(PBYIcusip74587V107)	3.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$11.7M	7.8% ($11.7M/$149.9M)	QoQ -2.95% (-$354.6K) YoY-
Bicara Therapeutics Inc.(BCAXcusip055477103)	643.4K	QoQ 0.00% (-1) YoY-	All Managers (Combined)	$8.4M	5.6% ($8.4M/$149.9M)	QoQ -25.20% (-$2.8M) YoY-
Protara Therapeutics, Inc.(TARAcusip74365U107)	1.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.5M	3.6% ($5.5M/$149.9M)	QoQ -19.31% (-$1.3M) YoY-
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	2.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.4M	3.6% ($5.4M/$149.9M)	QoQ -50.18% (-$5.5M) YoY-
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	1.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$5.1M	3.4% ($5.1M/$149.9M)	QoQ -50.00% (-$5.1M) YoY-
Verastem, Inc.(VSTMcusip92337C203)	779.5K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$4.7M	3.1% ($4.7M/$149.9M)	QoQ +503.00% (+$3.9M) YoY-
CYBIN INC.(CYBNcusip23256X407)	734.4K	QoQ 0.00% (-1) YoY-	All Managers (Combined)	$4.7M	3.1% ($4.7M/$149.9M)	QoQ -28.00% (-$1.8M) YoY-
Cardiff Oncology, Inc.(CRDFcusip14147L108)	1.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$4.5M	3.0% ($4.5M/$149.9M)	QoQ -27.64% (-$1.7M) YoY-
OptiNose, Inc.(OPTNcusip68404V209)	422.8K	QoQ 0.00% (+1) YoY-	All Managers (Combined)	$3.9M	2.6% ($3.9M/$149.9M)	QoQ +37.27% (+$1.1M) YoY-
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	1.1M	QoQ -0.67% (-7.7K) YoY-	All Managers (Combined)	$2.0M	1.4% ($2.0M/$149.9M)	QoQ -43.95% (-$1.6M) YoY-
X4 Pharmaceuticals, Inc(XFORcusip98420X103)	7.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.8M	1.2% ($1.8M/$149.9M)	QoQ -67.28% (-$3.6M) YoY-
Mural Oncology plc(MURAcusipG63365103)	1.3M	QoQ -1.27% (-16.4K) YoY-	All Managers (Combined)	$1.6M	1.1% ($1.6M/$149.9M)	QoQ -61.36% (-$2.5M) YoY-
Aura Biosciences, Inc.(AURAcusip05153U107)	590.5K	QoQ NEW(+590.5K) YoY-	All Managers (Combined)	$1.5M	1.0% ($1.5M/$149.9M)	QoQ NEW(+$1.5M) YoY-
BioAtla, Inc.(BCABcusip09077B104)	4.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.4M	0.9% ($1.4M/$149.9M)	QoQ -40.79% (-$972.5K) YoY-
Q32 Bio Inc.(QTTBcusip746964105)	803.4K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.3M	0.9% ($1.3M/$149.9M)	QoQ -52.03% (-$1.4M) YoY-